C

Cyclopharm Ltd
ASX:CYC

Watchlist Manager
Cyclopharm Ltd
ASX:CYC
Watchlist
Price: 1.405 AUD -6.64% Market Closed
Market Cap: 156.1m AUD
Have any thoughts about
Cyclopharm Ltd?
Write Note

Cyclopharm Ltd
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Cyclopharm Ltd
Total Equity Peer Comparison

Comparables:
R
RSH
IPD
COH
OIL
EMV

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
C
Cyclopharm Ltd
ASX:CYC
Total Equity
AU$47.5m
CAGR 3-Years
2%
CAGR 5-Years
28%
CAGR 10-Years
28%
R
Respiri Ltd
ASX:RSH
Total Equity
AU$2.6m
CAGR 3-Years
-30%
CAGR 5-Years
N/A
CAGR 10-Years
-12%
ImpediMed Ltd
ASX:IPD
Total Equity
AU$40.7m
CAGR 3-Years
17%
CAGR 5-Years
21%
CAGR 10-Years
12%
Cochlear Ltd
ASX:COH
Total Equity
AU$1.8B
CAGR 3-Years
3%
CAGR 5-Years
20%
CAGR 10-Years
19%
Optiscan Imaging Ltd
ASX:OIL
Total Equity
AU$13.9m
CAGR 3-Years
11%
CAGR 5-Years
37%
CAGR 10-Years
N/A
EMvision Medical Devices Ltd
ASX:EMV
Total Equity
AU$18.5m
CAGR 3-Years
23%
CAGR 5-Years
32%
CAGR 10-Years
N/A

See Also

What is Cyclopharm Ltd's Total Equity?
Total Equity
47.5m AUD

Based on the financial report for Jun 30, 2024, Cyclopharm Ltd's Total Equity amounts to 47.5m AUD.

What is Cyclopharm Ltd's Total Equity growth rate?
Total Equity CAGR 10Y
28%

Over the last year, the Total Equity growth was 36%. The average annual Total Equity growth rates for Cyclopharm Ltd have been 2% over the past three years , 28% over the past five years , and 28% over the past ten years .

Back to Top